The National on MSN1d
Two years on, are GLP-1 drugs such as Ozempic and Mounjaro here to stay?
In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...
Insurance Post1d
Will weight loss jabs shrink or expand insurer’s bottom lines?
As well as the ability to shrink waistlines, Emma Ann Hughes unpicks how weight loss jabs have the power to transform the ...
news.meaww1d
‘Bad ad for Ozempic’: Experts and fans slam celeb weight loss transformations at 2025 Golden Globes
Golden Globe Awards, many celebrities showcased dramatic physical transformations, leading to speculation about the use of ...
Opinion
BioSpace6dOpinion
Opinion: Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?
Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...